Humoral Response after a Fourth Dose with mRNA-1273 in Healthcare Workers with and without a History of SARS-CoV-2 Infection and Previously Vaccinated with Two Doses of BBIBP-CorV Plus BNT162b2 Vaccine

There is limited information on the kinetics of the humoral response elicited by a fourth dose with a heterologous mRNA1273 booster in patients who previously received a third dose with BNT162b2 and two doses of BBIBP-CorV as the primary regimen. We conducted a prospective cohort study to assess the...

Descripción completa

Detalles Bibliográficos
Autores principales: Gómez de la Torre, Juan C., Hueda-Zavaleta, Miguel, Cáceres-DelAguila, José Alonso, Muro-Rojo, Cecilia, Cruz-Escurra, Nathalia De La, Benítes-Zapata, Vicente A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221616/
https://www.ncbi.nlm.nih.gov/pubmed/37242998
http://dx.doi.org/10.3390/vaccines11050894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221616/
https://www.ncbi.nlm.nih.gov/pubmed/37242998
http://dx.doi.org/10.3390/vaccines11050894

Ejemplares similares